Post-operative Pain Clinical Trial
Official title:
A Randomised, Double- Blind, Placebo Controlled, Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Reducing Pain After Arthroscopy
The perception of pain is a complex process that is not yet fully understood. With
outpatient knee arthroscopy becoming standard of care, postoperative pain management has
become increasingly important in caring for patients. Traumeel S is a homeopathic complex
widely used in German-speaking Europe for orthopedic pain and inflammation. It contains a
mixture of medicinal plants and minerals, all highly diluted. In some recent studies,
Traumeel has shown anti-inflammatory and analgesic activity.
In this study, the efficacy of Traumeel S will be compared with placebo in reducing pain
during the first 48 hours after arthroscopy. Also compared will be 6 day pain levels,
analgesic consumption, quality of life, post operative knee function, quadriceps atrophy and
safety.
The study design is double blind RCT. 98 patients, aged 18-40 and undergoing arthroscopic
meniscectomy or chondroplasty will be enrolled in the trial. Patients will be randomized to
receive either intraoperative join irrigation with Traumeel S and oral treatment with
Traumeel S, or placebo irrigation and oral ingestion. Patients will continue to take active
or placebo medication for 6 days. Pain will be recorded daily by the patient in the patient
diary using an 11-point numerical rating score (NRS-11. Patients will also record daily
consumption of primary and "rescue" analgesics. Range of motion (RoM) will be measured on
days 6 and 30 post-operatively, and the Lysholm knee scale and circumference of thigh above
patella will be measured at 30 days. All these measures will be compared with baseline.
Patients will be contacted daily by the research assistant to encourage compliance and to
record their daily NRS and analgesic consumption in the CRF.
Status | Suspended |
Enrollment | 98 |
Est. completion date | |
Est. primary completion date | January 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Patients of either sex undergoing unilateral arthroscopy for menisectomy or chondroplasty, w/o ligament reconstruction . - Age 18 - 40 years. - Meeting none of exclusion criteria. Exclusion Criteria: - Participation in another clinical trial within 4 weeks prior to enrollment. - Inability to comply with the study protocol. - Impossibility to be reached during the whole follow-up period (7 days post operative) - Refused to give oral consent to the telephone interviews - Previous arthroscopy on ipsilateral knee. - Current use of analgesia for any other reason except for the knee complaint. - Any disease considered to inhibit wound healing (e.g. Diabetes mellitus, Berger, any PVD, DVT). - Known sensitivity to dipyrone or diclofenac |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Israel | Dept. of Orthopedic Surgery, Shaare Zedek Medical Center | Jerusalem |
Lead Sponsor | Collaborator |
---|---|
Shaare Zedek Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Degree of pain at rest, as recorded daily by the patient and by the study assistant in the CRF, using a 11 point (0-10) numerical rating score (NRS-11), during the first two post operative days. | 30d | Yes | |
Secondary | Degree of pain at rest, as recorded daily by the patient and by the study assistant in the CRF, using a 11 point (0-10) numerical rating score (NRS-11), during the six post operative days. | 30d | Yes | |
Secondary | Total amount of primary oral analgesic tablets ingested, as reported by the patient and the study assistant in the CRF from Day 0 to Day 5 (six days), using a discrete scale. | 30d | Yes | |
Secondary | Number of days on which oral rescue analgesic treatment was required, if any, as reported by the patient and the study assistant in the CRF, from Day 0 to Day 5 (six days) using a discrete scale. | 6d | Yes | |
Secondary | Degree of pain upon performance of RoM on days 5 and 30 postoperatively as compared with baseline, using a 11 point (0-10) numerical rating score (NRS), along a discrete scale. | 30d | Yes | |
Secondary | Knee function as measured by difference in RoM at 5 and 30 days postoperatively, as compared with baseline, on a continuous scale. | 30d | Yes | |
Secondary | Degree of atrophy of quadriceps, as measured by difference in circumference of thigh 15 cm proximal to the upper pole of the patella with knee in full extension on 30 days post-operatively, as compared with baseline, on a continuous scale. | 30d | Yes | |
Secondary | Difference in disease-related QoL, as measured by the difference in Lysholm knee score on 30 days post operatively as compared with baseline . | 30d | Yes | |
Secondary | Occurrence of adverse events. | 30d | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02489526 -
Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Colorectal Surgery
|
Phase 2 | |
Terminated |
NCT05146453 -
Sternotomies and PectoIntercostal Fascia Blocks in Fast-Track Cardiac Anesthesiology
|
Phase 4 | |
Completed |
NCT05635916 -
Trial of Liposomal Bupivacaine for TKA
|
Phase 4 | |
Recruiting |
NCT06028126 -
Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial
|
N/A | |
Not yet recruiting |
NCT03591172 -
Using Three Different Final Irrigants and Showing Their Effects on the Success of Revascularization
|
N/A | |
Completed |
NCT01667445 -
Evaluation of the Use of Spinal Epimorph in Total Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT01686802 -
Post-operative Oral Morphine Versus Ibuprofen
|
Phase 2 | |
Completed |
NCT01444924 -
Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery
|
Phase 2 | |
Completed |
NCT00968955 -
Effect of Local Infiltration Analgesia in Total Hip Arthroplasty
|
Phase 4 | |
Completed |
NCT00830089 -
Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery
|
N/A | |
Completed |
NCT00847093 -
LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery
|
Phase 4 | |
Terminated |
NCT00875862 -
Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks
|
Phase 4 | |
Completed |
NCT00390312 -
Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction
|
Phase 2 | |
Recruiting |
NCT05278494 -
Dextromethorphan for Treatment of Postoperative Pain
|
N/A | |
Recruiting |
NCT05973045 -
Investigation of the Effect of Distention Medium Temperature on Image Quality, Hyponatremia Risk, and Post-operative Pain in Operative Hysteroscopy
|
N/A | |
Not yet recruiting |
NCT04999670 -
Fascial Closure and Post-caesarean Pain
|
N/A | |
Enrolling by invitation |
NCT04346407 -
Dronabinol for Post-operative Pain After Lumbar Fusion
|
Phase 4 | |
Completed |
NCT03635515 -
Occurrence of Post-op Pain Following Gentlewave
|
N/A | |
Terminated |
NCT03201809 -
Comparison of Preoperative Ultrasound Guided Pectoralis Nerve Block Placement Versus Intra-operative Placement: A Prospective Randomized Trial
|
N/A | |
Completed |
NCT03254056 -
Fascial Closure Techniques Post-Operative Pain Laparoscopy
|
N/A |